Trial intelligence / Profile preview

Effectiveness of venlafaxine and duloxetine on chemotherapy-induced peripheral neuropathy

IRCT2015060922632N1Phase 2Completed

Sponsor
Kermanshah University of Medical Sciences
Start
May 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of venlafaxine and duloxetine in chemotherapy-induced peripheral neuropathy (CIPN) (2 arms), sponsored by Kermanshah University of Medical Sciences. Started May 2016; status: completed.

02

Drugs

venlafaxineduloxetine
03

Conditions

chemotherapy-induced peripheral neuropathy (CIPN)

Beyond the preview

Go deeper on IRCT2015060922632N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015060922632N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call